LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is headquartered in Burlington, Massachusetts.
| Revenue (TTM) | $256.28M |
| Gross Profit (TTM) | $182.81M |
| EBITDA | $78.75M |
| Operating Margin | 26.70% |
| Return on Equity | 16.60% |
| Return on Assets | 7.20% |
| Revenue/Share (TTM) | $11.29 |
| Book Value | $17.80 |
| Price-to-Book | 5.49 |
| Price-to-Sales (TTM) | 8.72 |
| EV/Revenue | 8.02 |
| EV/EBITDA | 21.35 |
| Quarterly Earnings Growth (YoY) | 41.70% |
| Quarterly Revenue Growth (YoY) | 11.20% |
| Shares Outstanding | $22.85M |
| Float | $21.27M |
| % Insiders | 6.56% |
| % Institutions | 100.22% |
Volatility is currently expanding